Lv1
10 积分 2023-04-07 加入
Metaplastic breast cancer: A review
4天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
3个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
3个月前
已完结
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial
3个月前
已完结
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3
9个月前
已完结
皖公网安备34019202002308
